Division of Research Spotlight
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
Kaiser Permanente study led by Minggui Pan, MD, PhD, and Laurel Habel, PhD, suggests ties among mutation type, tumor location, and survival.
Patients who made appointments to see their primary care doctors by video or over the phone did not seek substantially more follow-up care overall than those who had traditional in-person visits, according to Kaiser Permanente research published November 16 in JAMA Network Open.
A clinical decision support tool developed with predictive analytics could lead to more consistent patient preparation for elective surgery and reduce complications, according to Kaiser Permanente research published Nov. 10 in Annals of Surgery.
Patients with limited English proficiency who need a language interpreter for a telemedicine visit were less likely to choose a video visit for their first time than patients who did not need an interpreter, Kaiser Permanente research found.
The Kaiser Permanente Division of Research postdoctoral research program drew one of its largest-ever classes of fellows this year, building the strength of DOR's research portfolio. Seven fellows cover fields from diet to dementia, cancer to clinical informatics, to women's and children's health, and more.
The Patient-Centered Outcomes Research Institute-funded study will be co-led by research scientist and gastroenterologist Theodore R. Levin, MD, and focus on older adults with low-risk polyps.
A Kaiser Permanente analysis of more than 100,000 pregnancies in Northern California finds a 25% increase in the rate of cannabis use early in pregnancy after the pandemic began in spring 2020.
Kaiser Permanente study led by research scientist Alan Go, MD, supports eventual use of test for cystatin C — instead of creatinine — to advance health equity.
Physician researcher Robert Chang, MD, used a Kaiser Permanente Northern California patient registry to determine a patient's risk of having a large abdominal aortic aneurysm rupture.
Federal and Kaiser Permanente researchers combing the health records of 6.2 million patients found no serious health effects that could be linked to the 2 mRNA COVID-19 vaccines.